186 related articles for article (PubMed ID: 17336005)
21. Flow-through ultrasonic emulsification combined with static micromixing for aseptic production of microspheres by solvent extraction.
Freitas S; Rudolf B; Merkle HP; Gander B
Eur J Pharm Biopharm; 2005 Oct; 61(3):181-7. PubMed ID: 16009542
[TBL] [Abstract][Full Text] [Related]
22. Formulation aspects of biodegradable polymeric microspheres for antigen delivery.
Tamber H; Johansen P; Merkle HP; Gander B
Adv Drug Deliv Rev; 2005 Jan; 57(3):357-76. PubMed ID: 15560946
[TBL] [Abstract][Full Text] [Related]
23. Colloidal stability of pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms.
Santander-Ortega MJ; Jódar-Reyes AB; Csaba N; Bastos-González D; Ortega-Vinuesa JL
J Colloid Interface Sci; 2006 Oct; 302(2):522-9. PubMed ID: 16887138
[TBL] [Abstract][Full Text] [Related]
24. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
[TBL] [Abstract][Full Text] [Related]
25. PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA.
Mohamed F; van der Walle CF
Int J Pharm; 2006 Mar; 311(1-2):97-107. PubMed ID: 16414217
[TBL] [Abstract][Full Text] [Related]
26. Microcosmic mechanisms for protein incomplete release and stability of various amphiphilic mPEG-PLA microspheres.
Wei Y; Wang YX; Wang W; Ho SV; Qi F; Ma GH; Su ZG
Langmuir; 2012 Oct; 28(39):13984-92. PubMed ID: 22937802
[TBL] [Abstract][Full Text] [Related]
27. A novel preparation method for PLGA microspheres using non-halogenated solvents.
Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H
J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036
[TBL] [Abstract][Full Text] [Related]
28. Characterization and aerodynamic evaluation of spray dried recombinant human growth hormone using protein stabilizing agents.
Jalalipour M; Gilani K; Tajerzadeh H; Najafabadi AR; Barghi M
Int J Pharm; 2008 Mar; 352(1-2):209-16. PubMed ID: 18164150
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the poly(lactic-co-glycolic acid)/pluronic F127 for injection laryngoplasty in rabbits.
Lee JH; Kim DW; Kim EN; Park SW; Kim HB; Oh SH; Kwon SK
Otolaryngol Head Neck Surg; 2014 Nov; 151(5):830-5. PubMed ID: 25214547
[TBL] [Abstract][Full Text] [Related]
30. Ammonolysis-induced solvent removal: a facile approach for solidifying emulsion droplets into PLGA microspheres.
Kim J; Hong D; Chung Y; Sah H
Biomacromolecules; 2007 Dec; 8(12):3900-7. PubMed ID: 18031011
[TBL] [Abstract][Full Text] [Related]
31. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
32. Emulsion spray-drying for the preparation of albumin-loaded PLGA microspheres.
Giunchedi P; Conti B; Genta I; Conte U; Puglisi G
Drug Dev Ind Pharm; 2001 Aug; 27(7):745-50. PubMed ID: 11694022
[TBL] [Abstract][Full Text] [Related]
33. Preservation of lysozyme structure and function upon encapsulation and release from poly(lactic-co-glycolic) acid microspheres prepared by the water-in-oil-in-water method.
Pérez C; De Jesús P; Griebenow K
Int J Pharm; 2002 Nov; 248(1-2):193-206. PubMed ID: 12429473
[TBL] [Abstract][Full Text] [Related]
34. Poly(D,L-lactide-co-glycolide) dispersions containing pluronics: from particle preparation to temperature-triggered aggregation.
Fraylich M; Wang W; Shakesheff K; Alexander C; Saunders B
Langmuir; 2008 Aug; 24(15):7761-8. PubMed ID: 18570443
[TBL] [Abstract][Full Text] [Related]
35. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.
Lam XM; Duenas ET; Cleland JL
J Pharm Sci; 2001 Sep; 90(9):1356-65. PubMed ID: 11745788
[TBL] [Abstract][Full Text] [Related]
36. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
37. Design of Controlled Release PLGA Microspheres for Hydrophobic Fenretinide.
Zhang Y; Wischke C; Mittal S; Mitra A; Schwendeman SP
Mol Pharm; 2016 Aug; 13(8):2622-30. PubMed ID: 27144450
[TBL] [Abstract][Full Text] [Related]
38. A mathematical model for interpreting in vitro rhGH release from laminar implants.
Santoveña A; García JT; Oliva A; Llabrés M; Fariña JB
Int J Pharm; 2006 Feb; 309(1-2):38-43. PubMed ID: 16376037
[TBL] [Abstract][Full Text] [Related]
39. Renewal of the air-water interface as a critical system parameter of protein stability: aggregation of the human growth hormone and its prevention by surface-active compounds.
Wiesbauer J; Prassl R; Nidetzky B
Langmuir; 2013 Dec; 29(49):15240-50. PubMed ID: 24224491
[TBL] [Abstract][Full Text] [Related]
40. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
